BIO lauded House of Representatives for passing H.R. 701, which accelerates implementation of key capital formation provision in Jumpstart Our Business Startups (JOBS) Act. Bill gives U.S. Securities and Exchange Commission (SEC) deadline to complete rulemaking on reforms to Regulation A, which will, according to BIO's Jim Greenwood, "spur fundraising for emerging biotech companies, for which a $50 million capital influx could support groundbreaking research and stimulate job creation."
This story is related to the following:Green & CleanSearch for suppliers of: